Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128838) titled 'Observation Study on Meibomian Gland Function after Comprehensive Facial Platelet-rich Plasma Therapy' on July 27.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital, Jinan University
Condition:
Meibomian gland dysfunction
Intervention:
Standard treatment population:None
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2023-09-16
Target Sample Size: Standard treatment population:30;Platelet-rich plasma therapy for patients:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj...